LeMaitre Vascular Announces Q4 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/24/2026
- S&P 500 ends marginally lower as investors focus on US-Iran war
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oil gains on little sign of progress in US-Iran talks
- S&P 500 history shows strong gains across Fed hiking cycles: BCA
- JPMorgan upgrades CoreWeave on stronger compute pricing
- Plug Power COO resigns to join another company
- Bloom Energy falls as Oracle invokes force majeure on AI project
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oracle Sends Force Majeure Notice Over New Mexico Data Center - Bloomberg
- Akamai signs $11.6B deal with Anthropic, up to $20B potential
Lemaitre Vascular (LMAT) Tops Q4 EPS by 10c, Offers Guidance
February 19, 2019 4:07 PM ESTLemaitre Vascular (NASDAQ: LMAT) reported Q4 EPS of $0.30, $0.10 better than the analyst estimate of $0.20. Revenue for the quarter came in at $28.4 million versus the consensus estimate of $25.91 million.
GUIDANCE:
Lemaitre Vascular sees Q1 2019 EPS of $0.18-$0.20, versus the consensus of $0.20.... More
